We isolated the murine homologue Hic1, encoding a zinc-finger protein with a poxvirus and zinc-finger (POZ) domain and mapped it to mouse chromosome 11 in a region exhibiting conserved synteny to human chromosome 17. Comparison of genomic and cDNA sequences predicts two exons for the murine Hic1. The second exon exhibits 88% identity to the human HIC1 on DNA level. During embryonic development, Hic1 is expressed in mesenchymes of the sclerotomes, lateral body wall, limb and cranio-facial regions embedding the outgrowing peripheral nerves during their differentiation. During fetal development, Hic1 additionally is expressed in mesenchymes apposed to precartilaginous condensations, at many interfaces to budding epithelia of inner organs, and weakly in muscles. We observed activation of Hic1 expression in the embryonic anlagen of many tissues displaying anomalies in MDS patients. Besides lissencephaly, MDS patients exhibit facial dysmorphism and frequently additional birth defects, e.g. anomalies of the heart, kidney, gastrointestinal tract and the limbs (OMIM 247200). Thus, HIC1 activity may correlate with the defective development of the nose, jaws, extremities, gastrointestinal tract and kidney in MDS patients.
INTRODUCTION
HIC1 (hypermethylated in cancer) (1) resides in the MillerDieker syndrome (MDS) critical region on human chromosome 17p13.3. HIC1 encodes a C2-H2 zinc-finger protein with a poxvirus and zinc-finger (POZ) domain. The POZ domain, also known as broad complex, tramtrack, bric à brac (BTB) or zinc-finger N-terminal region (ZIN) domain, is a hydrophobic, ∼120 amino acid protein-protein interaction motif that is generally found at the N-terminus of either actin binding or DNA binding proteins. All tested POZ-C2-H2 zinc-finger proteins act as transcription factors. Several POZ proteins are localized in specific dots within the nucleus. Some POZ proteins have been implicated in chromatin remodeling (1,2; reviewed in ref. 3) . HIC1 is a potential tumor suppressor gene since it is hypermethylated and its expression is downregulated in several common types of cancer (4) . Moreover, loss of heterozygosity at the HIC1 locus was observed e.g. in medulloblastoma and lung cancers (5, 6 and references therein).
MDS (OMIM 247200) is a severe genetic disorder caused by hemizygous deletion of a critical region in 17p13.3, indicating haploinsufficiency of the involved genes. The syndrome is characterized by lissencephaly type I (smooth brain, agyria, pachygyria), characteristic facial appearence, and occasionally additional birth defects (7) (8) (9) (10) (11) . Many patients die within the first few years of life (9) . Lissencephaly has also been observed without facial dysmorphism, and was referred to as isolated lissencephaly (ILS). The type I lissencephaly observed in ILS and MDS is caused by deletions or mutations of the LIS1/PAFAH1B1 gene (12) (13) (14) (15) that codes for the 45 kDa subunit of the platelet activating factor acetylhydrolase (16) . The deletions observed in MDS always include LIS1/PAFAH1B1 and other telomeric loci (13, 17) . At least four genes reside in this region, these are MNT/ROX (encoding the MAX-interactor protein) at D17S379 (18, 19) , OVCA1/DPH2L and OVCA2 at D17S28/YNH37 (20, 21) and HIC1 at D17S5/YNZ22 (4).
Here we report the isolation, genomic structure, chromosomal localization and embryonic expression of the mouse Hic1 gene. Parts of the Hic1 expression territories in the embryo overlap with regions that exhibit abnormalities in MDS patients. The evaluation of its embryonic expression and the mapping of Hic1 to mouse chromosome 11 at 48 cM will be of importance for understanding the genetic basis of MDS. The relative sizes and locations of the murine Hic1 EST (IMAGE Consortium CloneID 337 300), two Hic1 cDNA clones (7-3-3 and 6-1) and the genomic Hic1 clone (G6-2) are given schematically. The exons are boxed and the intron is drawn as a line. The region encoding the POZ-domain is shaded and the region encoding the five zinc fingers is indicated by 'zf'. A potential TATA-box, the putative start codon, the stop codon and the poly(A) signal are indicated. For comparison, the human genomic HIC1 clone (accession no. L41919) (4) and a human EST (IMAGE Consortium CloneID 1520744, accession no. AA91086) are included. Human HIC1 was localized ∼2-3 kb centromeric to the marker YNZ22 (4). The dashed line represents unknown sequence and is not drawn into scale. In addition, the position of the short human genomic fragment (accession no. M21147) is indicated. This fragment was placed ∼1.8 kb centromeric to the marker YNZ22 (33) . (b) Northern blot analysis of total RNA from adult lung. The blot was probed with a fragment of Hic1 3′-UTR. The positions of the 18S and 28S rRNA bands are indicated.
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Isolation of the murine Hic1 and its genomic structure
For the human HIC1, a genomic clone (4) and an expressed sequence tag (EST) have been described. Screening of the EST database (dbEST) with the human HIC1 sequence identified its murine homologue. The corresponding EST clone from the IMAGE consortium (CloneID 337300) (22) encompassed 0.6 kb of 3′-untranslated region (3′-UTR) and was used as a probe to screen cDNA libraries (Fig. 1a) . Subsequent screening of two different mouse embryonic day 11 post-coitum (p.c.) cDNA libraries led to the isolation of two overlapping cDNA clones altogether spanning 3 kb. In addition, a genomic DNA library was screened using a subfragment of the isolated cDNA as a probe. A 6 kb fragment of a genomic Hic1 clone including 5′-and 3′-flanking regions was subcloned and sequenced.
Comparison of the genomic Hic1 and the cDNA sequences revealed two exons, separated by a 1451 nt intron (Fig. 1a) . The exon-intron boundaries AG/gtgggt . . . cag/G are in good agreement with the splice site consensus sequence (reviewed in ref. 23 ). The isolated cDNAs encompassed the second exon (2977 nt) and 48 nt of the presumptive first exon. Attempts to isolate further 5′ cDNA sequence were unsuccessful. Therefore, the 5′ extension of the first exon was predicted by combined northern blot (Fig. 1b) and sequence analysis of the genomic DNA clone. Genomic Hic1 revealed an in-frame ATG within a Kozak consensus initiation sequence (reviewed in ref. 24 ) 514 nt upstream of the splice donor site of the presumptive first intron. Using the binding site prediction program MatInspector V2.2 (25), a TATA-and a CAAT-box consensus sequence were identified upstream of the putative translation start site (Fig. 2) .
Transcription is predicted to start at an adenine, surrounded by pyrimidines, 35 nt downstream of the TATA box (26) , resulting in a predicted transcript of 3642 nt: a first exon of 665 nt and a second exon of 2977 nt. Northern analysis of total RNA from lung of adult mice revealed a single transcript of ∼3.7 kb (Fig. 1b) suggesting that we identified the complete transcribed region of Hic1 including the entire coding region. Both exons together predicted an open reading frame of 2676 nt, followed by 811 nt of 3′-untranslated sequence. Twenty-four nucleotides upstream of the poly(A) tail, a consensus polyadenylation signal is present (27) (Fig. 2) .
Deduced amino acid sequence and domain structure
The deduced Hic1 protein consists of 892 amino acids including a POZ domain and five C2-H2 zinc fingers at the C terminus (Fig.  3) . The N-terminal 172 residues exhibit no significant homology to any known protein and are rich in positively charged amino acids, containing a high percentage of Arg (13%) as well as Pro (13%) and Gly (12%). Following the POZ domain, Hic1 contains a cluster of basic amino acids, KKRLKRHGK (Fig. 2) . The stretch between the POZ domain and the zinc-finger region (amino acids 334-543) is rich in Pro (20%), Gly (14%) and Ala (10%). Moreover, database searches with the murine Hic1 protein sequence revealed similarities to the chicken γF-crystallin binding protein (γFBP) and to the deduced protein of a zebrafish EST (ICRFp524N033) that was sequenced and named hzp1 (hypermethylated in cancer, zinc-finger, POZ-domain) (Fig. 3) . Similarly to Hic1 and HIC1, γFBP encodes also a protein with a POZ domain and five zinc fingers. The deduced protein of the zebrafish hzp1 contains a POZ domain and only four zinc fingers corresponding to the first, third, fourth and fifth zinc fingers of either murine Hic1, human HIC1 or γFBP (Fig. 3b) . Interestingly, a short motif, GLDLSK (Fig. 2) , residing in the stretch between the POZ and the zinc-finger domain was identical among murine Hic1, chicken γFBP and zebrafish hzp1.
Chromosomal localization of Hic1
By fluorescence in situ hybridization (FISH) analysis, using the 16 kb genomic Hic1 clone G6-2 as a probe and a mouse chromosome 11 paint probe, Hic1 was localized to chromosome 11 (Fig. 4) . Further genetic mapping was achieved by an interspecific backcross mapping. A sequence length polymorphism in a PCR fragment of the 3′-UTR of Hic1 between C57BL/6J and Mus spretus (Fig. 2 ) was used to genetically map Hic1 on the C57BL/6J×M.spretus European Collaborative Interspecific Backcross (EUCIB; 28). A total of 130 animals was typed which allowed us to map Hic1 on chromosome 11, 2.3 ± 1.3 cM distal to the anchor locus D11Mit36 with a lod score of 32. Recombination events between Hic1 and interanchor microsatellite markers located Hic1 between D11Mit36 and D11Mit119 (Fig. 5a ). The map position at 48 cM on the EUCIB (Fig. 5b) was calculated from the Mbx database (28) .
Expression of the murine Hic1 mRNA
The spatio-temporal expression of the murine Hic1 gene during embryonic and fetal development was investigated by in situ hybridizations (ISHs) of whole mount embryos and on paraffin sections. As templates for riboprobes, the 0.6 kb EST (IMAGE Consortium CloneID 337300) (Figs 6-8, except Fig. 6c and c′) and the 2.3 kb cDNA clone 7-3-3 ( Fig. 6c and c′) were used. No obvious differences were observed in the expression patterns detected by riboprobes generated from both templates. ISHs with the 0.6 kb sense probe from the above EST clone did not yield any signal (data not shown). No expression was observed in the earliest stages investigated, Theiler stages (TS)12-14 (days 8-9 p.c.). At later stages, Hic1 expression was detected in restricted territories of somite derivatives, limb anlagen and cranio-facial mesenchymes (Fig. 6a) . Later, Hic1 expression was additionally observed in mesenchymes of the body wall and inner organs (Fig.  6b ).
Hic1 expression in sclerotomal and body wall mesenchymes
The mesenchymal sclerotomes and epithelial dermomyotomes arise from the mesodermal segments, the somites. The sclerotomes differentiate into axial skeleton and perineural mesenchymes embedding the spinal cord and trunk peripheral nerves. The dermomyotomes give rise to part of the dermis and the myotomes, progenitors of skeletal muscles (reviewed in ref. 29) . Hic1 expression in somite derivatives was first restricted to stripes along their segmental borders spreading in a rostro-caudal direction ( Fig. 6a and c, arrowheads) starting in the occipitocervical region of TS15 (day 9.5 p.c.) embryos (data not shown). Transverse cuts of whole embryos hybridized at TS17 (day 10.5 p.c.) revealed that Hic1 expression was localized to mesenchymes medially to (underlying) the epithelial dermomyotomes and myotomes (Fig. 6c′ ) that are considered to be sclerotome derivatives (30, 31) . Interestingly, Hic1 expression was restricted to the dorsal-most (epaxial) edges and ventral (hypaxial) aspects of the mesenchymes underlying the dermomyotomes (Fig. 6c′ , eST and hST). This spatial restriction of Hic1 expression was Figure 6 . Whole mount in situ hybridizations detecting Hic1 expression in somite derivatives and body wall of mouse embryos at TS17-20. Digoxigenin-labelled Hic1 antisense riboprobes detected expression in somite derivatives (a and b, So) that were localized to spatially separated epaxial and hypaxial mesenchymes, firstly, of the sclerotomes (a, c, d, e and g, arrowheads and ST), and later, also of the lateral body wall (d-h, lM). Epaxial and hypaxial Hic1 expressions in these territories are sharply delineated against the non-expressing mesenchyme of the intercalated, central somite derivatives (g and h, stippled lines mark central territory). Hic1 is also expressed in the limb anlagen (a, b, e, f, g and h), in cranio-facial regions (a and b, arrows, and f), and in mesenchymes associated with spinal ganglia (d, f and h, black arrows) and with skeletal condensations (f and h, VA). (a, b, c, f, g and h) Lateral views; (d and e) dorso-lateral views; (e′) ventral view; (c′ and d′) transverse cuts from TS17 and TS19 whole mount embryos, respectively. The horizontal lines connect specific aspects of the Hic1 expression pattern in lateral views of whole embryos (c and d) and transverse cuts (c′ and d′). Rostral is to the left (except in c). The white arrows mark bright blue precipitate in the medial mesenchymes typically arising in the depth of whole embryos (d′ and h). AT, atlas; c, central; cer, cervical; DM, dermomyotome; e, epaxial; FL, fore limb bud; HL, hind limb bud; G, gut; h, hypaxial; mM, medial mesenchyme; lM, lateral mesenchyme; P, pancreas; SB, somitic bud; SG, spinal ganglion; So, somite derivatives; ST, sclerotome; tho, thoracic; TS, Theiler stage; VA, vertebral arch anlage.
at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from retained at later embryonic stages. Medially to (underlying) the dermomyotome derivatives, Hic1 was expressed in separated epaxial and hypaxial mesenchymes at TS17-18 (day 10.75 p.c.; Fig. 6e and g, eST and hST) and TS19 (day 11.5 p.c.; Figs 6d′ and 7a, mM). Epaxially, Hic1 was also expressed in the mesenchyme between and dorsally to the spinal ganglia where the dorsal roots enter the spinal cord (Fig. 6d , f and h, black arrows).
During maturation of somite derivatives, Hic1, in addition to its expression in epaxial and hypaxial sclerotome moieties, is activated in mesenchymes laterally to (overlying) the dermomyotomes spreading in a rostro-caudal direction (Fig. 6e, elM and  hlM) . Finally, continuous bands of Hic1 expression form at the levels of the epaxial and hypaxial somite derivatives (Fig. 6h, elM and hlM). Taken together, from TS17-18 onwards, the epaxial and hypaxial dermomyotome derivatives are surrounded medially and laterally by mesenchymes expressing Hic1 (Figs 6e and e′, and 7a and b). Also during fetal development, Hic1 expression is retained in distinct epaxial and hypaxial mesenchymal territories associated with the muscles (Fig. 7d and h, eM and hM) . Moreover, Hic1 expressing mesenchymes embed the developing peripheral nerves (Fig. 7a-d) suggesting a role for Hic1 in the specification of perineural mesenchymes from earliest stages of PNS development onwards. Furthermore, during maturation of the body wall, Hic1 expression transiently outlined precartilaginous condensations of vertebral arches and ribs (Figs 6f and h, and 7b).
It is worth noting that the Hic1-expressing mesenchymes associated with the epaxial and hypaxial somite derivatives are sharply delineated against a non-expressing territory overlying the intercalated, central somite derivatives ( Fig. 6g and h ; stippled lines delineate central somite territories). These borders in the expression of Hic1 appeared to persist until TS21-22 (days 12.5-13.5 p.c.) of fetal development: the epaxial and hypaxial branches of the peripheral nerves are embedded by mesenchymes expressing Hic1, whereas the spinal nerves and most proximal branches of the peripheral nerves are surrounded by nonexpressing mesenchymes (Fig. 7d and h ).
Expression of Hic1 in limb and cranio-facial mesenchymes
At TS17-18, Hic1 expression started in limb bud mesenchymes near the dorsal and ventral surfaces (Fig. 6a, e and g ). Later, Hic1 expression in the limbs diversified into many smaller territories (Fig. 6b, f and h ). At TS19, Myod1-expressing muscle anlagen were partly apposed to Hic1-expressing territories (data not shown). ISHs on transverse sections of TS19-22 fetuses revealed Hic1 expression in mesenchymes that outlined the precartilaginous condensations of limb skeletal elements and separated them (Fig. 7e, f′ and h ). At TS21, Hic1, in addition, was strongly up-regulated along the rostral and caudal edges of the limb stump (Fig. 7g, arrows) . Later, strongest expression was found distally, in the digits (Fig. 7f, arrows) . Moreover, peripheral nerves also in the limb anlagen were embedded in mesenchymes that expressed high levels of Hic1 (Fig. 7c, e and h) .
In cranio-facial mesenchymes, expression of Hic1 was detected near the joint anlage of the jaw [Figs 6a and b, and 8a (short arrow)] and in the nose region [Figs 6a and b, and 8a (long arrow)]. At TS19, Hic1 was also expressed in mesenchymes connecting the trigeminal ganglion with the angle of the jaw and the eye (Figs 6b, and 8a and d) . Moreover, mesenchymes in the caudal branchial arches and around the peripheral cranial nerves expressed Hic1 (Fig. 8a, c, d and e) . At TS19, Hic1 and Col2a1 were expressed in mutually exclusive territories (Fig. 8a and b) as in the limb buds. Myod1 expression in the anlagen of eye and jaw muscles shared interfaces and partly overlapped with adjacent Hic1 expression territories (Fig. 8d and d′) . ISHs on sections of TS19-22 embryos revealed that Hic1 expression in the nose, branchial furrows, branchial pouches (including thymus anlage) and the salivary glands, was localized to mesenchymes adjacent to budding epithelia (Fig. 8c, e, f and g ). Finally, mesenchymes associated with many muscle anlagen in branchial to cervical regions expressed weaker levels of Hic1 at TS21/22 (data not shown).
Expression of Hic1 in mesenchymes facing epithelia of inner organs
From early fetal development onwards, Hic1 expression was detected in restricted moieties of pancreas, gut, adrenal gland, kidney anlagen and urogential ridge (Figs 6b and h, 7a and b, and 8h). ISHs on sections of TS19-22 fetuses, in addition, identified expression of Hic1 in restricted mesenchymal territories of esophagus, trachea, lung, diaphragm and stomach. In young anlagen of inner organs, mesenchymal Hic1 expression was found next to epithelia, whereas in more mature anlagen it was also localized more cortically (data not shown). Taken together, many Hic1-expressing mesenchymes were facing epithelial buddings within inner organ anlagen, as well as the still epithelial extremities of the elongating epaxial and hypaxial somite derivatives.
DISCUSSION
The novel murine Hic1 gene was isolated and characterized. Sequence analysis of the murine Hic1 gene revealed that it represents the murine orthologue of the previously described human HIC1 (4). Furthermore, Hic1 is closely related to the chicken γFBP (32) and the zebrafish hzp1 that was sequenced in this study. Hic1 is activated in embryonic anlagen of some tissues affected in MDS patients. The embryonic expression of Hic1 is in line with a phenotypic contribution of HIC1 to MDS.
Genomic organization of murine Hic1
The comparison of the isolated mouse cDNA clones with the genomic sequence revealed that the murine Hic1 gene contains two exons, separated by a 1.5 kb intron. For the human HIC1 gene only a genomic clone was described and the exon-intron structure was predicted to have three exons (4) . The presumptive first human 5′-untranslated exon is not contained in the isolated murine cDNA and in a human HIC1 EST (Fig. 1a) . The human second and third exon and the intron (500 bp) in between correspond to the second murine exon. The coding region of the second murine Hic1 exon exhibits 88% identity on DNA level to the corresponding region of the human HIC1 gene. Moreover, the murine Hic1 and human HIC1 nucleotide sequences exhibit 74% identity in the 3′-UTR and 79% identity in ∼650 bp of the 3′ region of the mouse intron directly upstream of the second murine exon. Interestingly, the exon-intron boundary of the first murine exon exhibited 96% (56 of 58 nt) identity to a human genomic fragment (accession no. M21147; ref. 33) (Fig. 1a) . This genomic fragment is contained in a human HIC1 EST (Fig. 1a) . It is thus Figure 7 . ISHs detecting Hic1 expression in mesenchymes surrounding peripheral nerves and limb anlagen at TS19-23. At TS19, Hic1 is expressed in epaxial and hypaxial mesenchymes directly adjacent to the still epithelial somite derivatives (including embryonic muscle anlagen) and the condensing skeletal anlagen (including rib anlagen) (a and b). Moreover, Hic1 is expressed in mesenchymes facing epithelia of inner organs [gut in (a); urogenital ridge in (b)]. At TS22, Hic1 expression is associated with epaxial and hypaxial muscles (d). Hic1 is expressed in mesenchymes surrounding the earliest condensations of the skeletal anlagen of the limb anlagen (e-h). Later, Hic1 expression is also localized to distinct rostral and caudal limb mesenchymes (f and g, arrows). In all stages, Hic1 expression is detected in mesenchymes which embed the elongating peripheral nerves (a-e, and h). Paraffin sections were cut transversally (a, d, e, e′ and h), sagittally (b) and horizontally (c). (e′) HE-staining of a section adjacent to that shown in (e). Section planes of (f′) and (h) are shown in (f) and (g), respectively. conceivable that also the human HIC1 contains an additional exon in the 5′-region. The reported genomic structure of human HIC1 (4) might represent an alternative transcript.
Chromosomal localization of Hic1
In this study Hic1 was mapped to mouse chromosome 11 at 48 cM employing the EUCIB. Its human orthologue was placed at 17p13.3 (4). Other genes that have been localized on the EUCIB, are Cryba1 at 45 cM, Cacna1g at 60 cM and Nfe2l1 at 61 cM. However, the human orthologues of these three genes map to 17q (Fig. 4b) . Thus, Hic1 seems to be localized in a region that exhibits homology to a linkage group on human chromosme 17q.
The order of loci that were placed on the Mouse Genome Database (MGD) map support this view (http://www.informatics. jax.org/map.html ). This suggests that chromosomal rearrangements in this region have occured between man and mouse. Similar discontinuities in the gene order within regions of conserved synteny were found among mouse chromosome 16 and the human DiGeorge syndrome region on 22q11.2 (34) and among human chromosome 5 and mouse chromosome 11 (35) .
Sequences from the human MDS chromosomal region hybridized to mouse chromosome 11 (36) . In addition, the gene order and relative distance of genes localized inside (LIS1/PAFAH1B1, MNT/ROX) and outside (14-3-3e/YWHAE) the MDS critical chromosomal region are conserved between man and mouse. The three genes reside within 1 Mb (37) and have been placed at 44 cM on the mouse chromosome 11 in the MGD map. In human, HIC1 is localized between MNT/ROX and 14-3-3e/YWHAE. For the establishment of an MDS mouse model it would be extremely important to determine the precise localization of Hic1 in relation to these genes.
Comparison of the expressions of Hic1 and γFBP during development
The POZ domain and the zinc-finger region of the murine Hic1, the human HIC1 and the chicken γFBP proteins are highly identical, thus suggesting that these proteins might exert similar functions. HIC1 is expressed in all adult tissues analysed (4), but its embryonic expression pattern is not known. Comparison of the murine Hic1 expression and that of a related gene in chicken embryos, γFBP, revealed some similarities, but also some differences. γFBP and Hic1 might share expression territories in the sclerotomes, head mesenchyme, developing extremities, pharynx, esophagus, tongue, urogenital ridge, intestine, vertebral arch and rib associated mesenchymes (32 and this study). Despite the absence of detailed information on the γFBP expression, these general similarities raise the possibility of common functions of these structurally related genes in differentiation of restricted mesenchymes. Moreover, γFBP was expressed during lens differentiation and functionally implicated in the regulation of the γF-Crystallin (Crygf) gene (32) . However, we did not detect any expression of the murine Hic1 gene in lenses at embryonic, fetal, postnatal (p1, p7, p14, p21), and adult stages by means of ISHs of whole embryos and on paraffin sections (Fig. 8d , and data not shown). Thus, it is not likely that the murine Hic1 gene is implicated in lens differentiation.
Hic1 is expressed in perineural mesenchymes
Embryonic expression of Hic1 was detected in subterritories of the sclerotomes, first intersomitically, and shortly later, in the rostral sclerotome halves. Formation of the segmental array of the components of the peripheral nervous system (PNS), the peripheral ganglia, peripheral nerves and their branches, depends on the permissive properties of the rostral sclerotome halves and the repulsive properties of the caudal sclerotome halves (38) (39) (40) (41) . Fetal expression of the Hic1 gene was observed in the mesenchymes embedding elongating peripheral nerves in the head, trunk and limbs. Moreover, the spatio-temporal dynamics of Hic1 expression appeared to reflect the course of branching in the peripheral nerves whose target regions are situated more and more peripherally (42, 43) . Thus, Hic1 expression might play a role in the specification of the sclerotome-and lateral platederived as well as cranial mesenchymes implicated in the spatial organization of the PNS. Finally, Hic1 was expressed in mesenchymes at many sites where peripheral nerves probably make contact with the developing muscles and the visceral organs. Interestingly, also the Drosophila POZ-C2-H2 zincfinger protein lola (longitudinals lacking) plays essential roles in PNS development; lola is required for axon growth and guidance of the intersegmental nerves (44) . Moreover, the Drosophila POZ-C2-H2 zinc-finger BR-C (broad complex) regulates muscle attachment in Drosophila (45) . The possible contribution of the HIC1 gene to the development of peripheral nerves remains to be elaborated, because also the LIS1/PAFAH1B1 and the MNT/ROX genes may be implicated in peripheral nerve development (12, 46) . Moreover, in syndromes encompassing lissencephaly, it is difficult to decide if the primary reasons of functional deficiencies of the PNS reside solely in the brain or also the PNS itself.
Hic1 is activated in embryonic anlagen of tissues that are affected in MDS patients
Besides lissencephaly, MDS patients exhibit facial dysmorphism and frequently additional birth defects, e.g. anomalies of the heart, kidney, gastrointestinal tract and the limbs (7) (8) (9) (10) (11) . Genes deleted in MDS patients are from the centromere to the telomere: LIS1/PAFAH1B1, MNT/ROX, HIC1, OVCA1/DPH2L and OVCA2. In the ILS, mutations and deletions of the LIS1/PAFAH1B1 gene were observed (12) (13) (14) , and in several cases, also the locus D17S379 residing in the 3′-UTR of the MNT/ROX gene is deleted (10, 13) . However, the deletions in MDS patients always extend more distally than those in the deleted ILS patients (13) . ILS patients sometimes exhibit subtle cranio-facial anomalies reminiscent of those in MDS patients, like bi-temporal hollowing and small jaw, but they rarely have other consistent anomalies (10), strongly suggesting that loss of function in the LIS1/PAFAH1B1 and MNT/ROX genes does not cause the defects in cranio-facial and limb development in MDS patients.
This raises the possibility that other candidate genes in the MDS critical region may be implicated in the defects other than lissencephaly. OVCA1/DPH2L and OVCA2 contain no known functional motifs and are ubiquitously expressed in adult tissues (21) and their developmental expression is not known. In this study, we present the mouse gene Hic1, the orthologue of HIC1, and the striking correlation of its expression with additional sites of defective development in MDS patients.
First, MDS patients exhibit a characteristic facial appearence consisting of a prominent forehead, small jaw (micrognathia), bi-temporal hollowing, short nose with upturned nares, a broad nasal bridge and a protuberant upper lip. Frequently, wrinkling of the forehead was also observed (9) . During development, Hic1 is expressed in the first branchial arch that gives rise to the maxillar and mandibular components of the jaw and the lips. In addition, Hic1 expression was observed in the mesenchyme surrounding the infolding nasal epithelium in embryonic and fetal development. Thus, the developmental expression of Hic1 in spatially restricted cranio-facial mesenchymes whose derivatives are affected in MDS patients suggests that HIC1 may be implicated in the morphogenesis of the nose, jaw and lips.
Secondly, frequently, clinodactyly and sometimes syndactyly were observed in MDS patients (9) . Hic1 is expressed in restricted domains of the limb mesenchyme, surrounding the skeletal condensations, as well as in rostral and caudal mesenchymes of each digit anlagen. Thus, loss of HIC1 function may be involved in the limb anomalies observed in MDS.
Thirdly, less frequently, inguinal hernia/omphalocoele was associated with MDS, leading to the suggestion that a gene involved in the closure of the lateral folds or in the return of the midgut from the body stalk to the abdomen during weeks 5-11 of gestation resides at 17p13.3 (11) . Hic1 is expressed in the lateral body wall and in the gut. This raises the possibility that its human homologue might play a role in the omphalocoely observed in MDS patients. Finally, two patients with kidney defects were reported and one case with a duodenal atresia (7, 8) . Hic1 is expressed during development of the gut and the kidney.
In conclusion, the mouse homologue of HIC1, during embryonic development, is expressed in restricted territories of facial mesenchymes (in the branchial arches, surrounding the infolding nasal epithelium and the facial nerves), in the lateral body wall, kidney, gut and limb anlagen. All these expression territories correspond to sites where developmental defects are observed in MDS patients. Therefore, alterations in the gene dosage of the putative transcription factor HIC1 might be involved in the anomalies observed in MDS patients, that are hemizygous for HIC1. An example for gene dosage effects of transcription factors is the Pax family of paired domain proteins. All analyzed heterozygous Pax null mutants exhibit severe developmental defects due to haploinsuffiency (reviewed in ref. 47) .
The generation and investigation of heterozygous and homozygous Hic1 knock-out mutant mice will help to reveal if the gene dosage of Hic1 is critical for development and if its human orthologue might be involved in the MDS.
MATERIALS AND METHODS
Animals and embryos
Mice were obtained from the GSF animal facilities. C3H/El and (102/El × C3H/El)F 1 hybrid mice were used for the supply of all tissues and the preparation of embryos; for the latter also C57BL/6 mice were used. Staging of embryos was performed according to Kaufman (48) . Individual somites and early vertebral condensations were identified according to Spörle and Schughart (49) .
Expressed sequence tags
The murine EST of the IMAGE Consortium [CloneID 337300, partial sequence under accession no. W20732; (22) ] was obtained from the Human Genome Mapping Project-Resource Centre (HGMP-RC, Cambridge, UK).
The zebrafish EST (ICRFp524N033, partial sequence under accession nos AA497316 and AA497240) was kindly provided by Dr M. Clark (Resource Centre of the German Human Genome Project at the Max-Planck-Institute for Molecular Genetics, Berlin, Germany).
Isolation of the murine Hic1
The 0.6 kb EcoRI-NotI insert of the IMAGE Consortium CloneID 337300 was labelled with [α-32 P]dCTP (Amersham, Braunschweig, Germany) by random priming using the Megaprime DNA labelling system (Amersham) to screen a mouse embryonic day 11 cDNA library of the mouse strain SwissWebster (Novagen, Madison, WI) using stringent hybridization conditions (50% formamide, 5× SSC, 5× Denhardt's, 0.1% SDS, 100 µg/ml herring sperm DNA, 42_C). Filters (Qiabrane Nylon; Qiagen, Hilden, Germany) were washed in 0.1× SSC/0.1% SDS at 50_C. Sixteen positive clones were isolated and subcloned into pSHlox-1 by in vivo excision. Both strands of the largest clone (7-3-3, 2.3 kb) were sequenced. To obtain the 5′ region, a second mouse embryonic day 11 cDNA library of the mouse strain SwissWebster (kindly provided by Dr G. Borsani, TIGEM, Milano, Italy) was screened using a 935 bp fragment (EcoRINdeI) of the 5′ end of clone 7-3-3 as a probe. One of the isolated clones (6-1), revealing a 1.9 kb insert, exhibited further 5′-coding region of Hic1 and was subcloned into the EcoRI sites of pBluescript KS and sequenced (Sequiserve, Vaterstetten, Germany).
A genomic Hic1 clone was isolated by screening a genomic λDASH DNA library of the mouse strain 129/SV (50) using the 935 bp EcoRI-NdeI fragment of the 5′ region of clone 7-3-3 as a probe. One positive clone (G6-2), containing an ∼16 kb insert, was further analyzed. An ∼6 kb BamHI fragment of this clone was subcloned into pBluescript KS and sequenced.
Sequence analyses were performed with Gene works 2.45N, clustalW 1.7, MatInspector V2.2 (25) (http://www.gsf.de/biodv/ ) and the 'BLAST' network service (51) .
Northern analysis
Total RNA from frozen tissues was isolated with RNeasy (Qiagen). Twenty micrograms of total RNA were separated on a 1% agarose gel according to Sambrook et al. (52) , transferred onto nylon membranes (Qiabrane Nylon Plus; Qiagen) and UV crosslinked (Stratalinker; Stratagene, Heidelberg, Germany). The 0.6 kb EcoRI-NotI insert of the IMAGE Consortium CloneID 337300 was labelled with [α-32 P]dCTP (Amersham). Labelling and hybridization was performed as described above. Filters were exposed to X-ray film (Kodak XAR; Eastman Kodak Company, New York, NY) at -80_C with two intensifying screens for 3 days.
Chromosomal localization
FISH was performed on metaphase chromosome preparations obtained from mouse bone marrow cells according to standard procedures. The ∼16 kb genomic Hic1 clone G6-2 in λDASH was labelled with biotin-dUTP using the Bio-Prime DNA Labelling System (Gibco BRL, Eggenstein, Germany). The specific chromosome 11 paint probe was obtained from Appligene Oncor; (Heidelberg, Germany). Hybridizations were performed according to Pinkel et al. (53) . Metaphase chromosomes were analyzed under an Axiophot microscope (Zeiss, Germany), and pictures were taken by digitizing the microscopic image with the computer program ISIS3 (Metasystems, Altlußheim, Germany) and adapted in Adobe Photoshop 3.0.
Genomic DNA samples from the EUCIB were obtained from the HGMP-RC (28) . A polymorphism between M.spretus and C57BL/6J was detected in the 3′-UTR of Hic1 using the primer pair 5′-AACCCTGCCTCTCCCTGTGGC-3′/5′-GTAGGGCT-GGGAGCGTCC-3′. To confine the amplified products, the PCR fragments of M.spretus and C57BL/6J were cloned into the pCR™2.1 vector (Invitrogen, Leek, The Netherlands) and sequenced. A 99 bp fragment was amplified from C57BL/6J and a 95 bp fragment from M.spretus. PCR was run in a GeneAmp PCR System 9600 (Perkin Elmer, Weiterstadt, Germany) using the following conditions: 6 min 94_C, 30 cycles of 94, 60 and 72_C each step lasted for 30 s and a final extension step for 10 min at 72_C. For each PCR reaction, 20 ng genomic DNA, 2 U Taq polymerase (Gibco BRL) 1× Taq reaction buffer (Boehringer Mannheim, Germany), 200 µM of each dNTP (Boehringer Mannheim), 1.5 mM MgCl 2 , 0.25 µM of each oligonucleotide in a total volume of 20 µl were used. Bands were separated on an 8% polyacrylamide/1× TBE gel. A total of 130 backcross animals were typed for the Hic1 locus. Genetic linkage to EUCIB anchor loci was analysed using the Mbx program (28) .
